Susquehanna International Group, LLP Kamada LTD Transaction History

Susquehanna International Group, LLP

9 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2024 Aug 15, 2024	SELL	$4.78 - $5.75 $9,918 - $11,931	-2,075 Reduced 7.31%	26,321 $130,000
Q1 2024 May 07, 2024	BUY	$5.58 - $6.42 $67,110 - $77,213	12,027 Added 73.47%	28,396 $159,000
Q4 2023 Feb 14, 2024	BUY	$4.14 - $6.22 $67,767 - $101,815	16,369 New	16,369 $100,000
Q4 2022 Feb 14, 2023	BUY	$3.79 - $4.84 $38,426 - $49,072	10,139 New	10,139 $40,000
Q1 2022 May 16, 2022	SELL	$5.43 - $6.81 $96,105 - $120,530	-17,699 Closed	0 $0
Q4 2021 Feb 14, 2022	SELL	$5.21 - $6.82 $32,484 - $42,522	-6,235 Reduced 26.05%	17,699 $116,000
Q3 2021 Nov 15, 2021	BUY	$5.25 - $5.87 $125,653 - $140,492	23,934 New	23,934 $127,000
Q2 2021 Aug 11, 2021	SELL	$5.67 - $6.33 $166,539 - $185,924	-29,372 Closed	0 $0
Q1 2021 May 17, 2021	BUY	$6.02 - $8.06 $176,819 - $236,738	29,372 New	29,372 $182,000

6.48M

200

Ticker KMDA
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 44,800,500
Market Cap $264M
Description
Kamada Ltd. provides plasma-derived protein therapeutics. It operates in two segments, Proprietary Products and Distribution. The company offers KAMRAB/KEDRAB for prophylaxis of rabies disease; CYTOGAM for prophylaxis of cytomegalovirus disease in kidney, lung, liver, pancreas, heart, and heart/lung transplant; WINRHO SDF for immune thrombocytop...

Get notified when there are updates to the investment portfolio of Susquehanna International Group, LLP, based on Form 13F filings with the SEC.

Stay updated on Susquehanna International Group, LLP with notifications on news.